266 related articles for article (PubMed ID: 27194890)
61. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis.
Gadelha T; André C; Jucá AA; Nucci M
Cerebrovasc Dis; 2005; 19(1):49-52. PubMed ID: 15528884
[TBL] [Abstract][Full Text] [Related]
62. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
63. Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism.
Varela ML; Adamczuk YP; Forastiero RR; Martinuzzo ME; Cerrato GS; Pombo G; Carreras LO
Thromb Res; 2001 Dec; 104(5):317-24. PubMed ID: 11738073
[TBL] [Abstract][Full Text] [Related]
64. The Association between Parameters of Erythrocytes Morphology and Thrombophilia-related Mutations.
Oz O; Gonel A
Rev Recent Clin Trials; 2022; 17(1):40-45. PubMed ID: 34814821
[TBL] [Abstract][Full Text] [Related]
65. Thrombophilia and Recurrent Pregnancy Loss: The Enigma Continues.
Barut MU; Bozkurt M; Kahraman M; Yıldırım E; Imirzalioğlu N; Kubar A; Sak S; Ağaçayak E; Aksu T; Çoksüer H
Med Sci Monit; 2018 Jun; 24():4288-4294. PubMed ID: 29932168
[TBL] [Abstract][Full Text] [Related]
66. PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs.
Balta G; Altay C; Gurgey A
Am J Hematol; 2002 Oct; 71(2):89-93. PubMed ID: 12353306
[TBL] [Abstract][Full Text] [Related]
67. Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta-analysis.
Ma SD; Wang J; Bezinover D; Kadry Z; Northup PG; Stine JG
Res Pract Thromb Haemost; 2019 Oct; 3(4):658-667. PubMed ID: 31624785
[TBL] [Abstract][Full Text] [Related]
68. Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders.
Fortea JI; Carrera IG; Puente Á; Cuadrado A; Huelin P; Tato CÁ; Fernández PÁ; Montes MDRP; Céspedes JN; López AB; Sanchez FJG; Hoyos ML; Crespo J; Fábrega E
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32878264
[TBL] [Abstract][Full Text] [Related]
69. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
Heller C; Schobess R; Kurnik K; Junker R; Günther G; Kreuz W; Nowak-Göttl U
Br J Haematol; 2000 Nov; 111(2):534-9. PubMed ID: 11122096
[TBL] [Abstract][Full Text] [Related]
70. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis.
Lakhoo J; Gaba RC
Diagn Interv Imaging; 2016 Nov; 97(11):1085-1093. PubMed ID: 27481577
[TBL] [Abstract][Full Text] [Related]
71. Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.
How J; Zhou A; Oh ST
Ther Adv Hematol; 2017 Mar; 8(3):107-118. PubMed ID: 28246554
[TBL] [Abstract][Full Text] [Related]
72. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis.
Erkan O; Bozdayi AM; Disibeyaz S; Oguz D; Ozcan M; Bahar K; Karayalcin S; Ozden A; Bozkaya H; Yurdaydin C; Uzunalimoglu O
Eur J Gastroenterol Hepatol; 2005 Mar; 17(3):339-43. PubMed ID: 15716659
[TBL] [Abstract][Full Text] [Related]
73. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight.
de Moerloose P; Wutschert R; Heinzmann M; Perneger T; Reber G; Bounameaux H
Thromb Haemost; 1998 Aug; 80(2):239-41. PubMed ID: 9716145
[TBL] [Abstract][Full Text] [Related]
74. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults.
Balasa VV; Gruppo RA; Glueck CJ; Stroop D; Becker A; Pillow A; Wang P
Thromb Haemost; 1999 May; 81(5):739-44. PubMed ID: 10365747
[TBL] [Abstract][Full Text] [Related]
75. Survival after splanchnic vein thrombosis: A 20-year nationwide cohort study.
Søgaard KK; Darvalics B; Horváth-Puhó E; Sørensen HT
Thromb Res; 2016 May; 141():1-7. PubMed ID: 26945454
[TBL] [Abstract][Full Text] [Related]
76. A Nationwide Analysis of Budd-Chiari Syndrome in the United States.
Alukal JJ; Zhang T; Thuluvath PJ
J Clin Exp Hepatol; 2021; 11(2):181-187. PubMed ID: 33746442
[TBL] [Abstract][Full Text] [Related]
77. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
[TBL] [Abstract][Full Text] [Related]
78. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.
Koylu MT; Kucukevcilioglu M; Erdurman FC; Durukan AH; Sobacı G; Torun D; Tunca Y; Ayyildiz O
Ophthalmic Genet; 2017; 38(4):352-356. PubMed ID: 28085519
[TBL] [Abstract][Full Text] [Related]
79. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
[TBL] [Abstract][Full Text] [Related]
80. The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis.
Smalberg JH; Koehler E; Darwish Murad S; Plessier A; Seijo S; Trebicka J; Primignani M; de Maat MP; Garcia-Pagan JC; Valla DC; Janssen HL; Leebeek FW;
Blood; 2011 Apr; 117(15):3968-73. PubMed ID: 21364191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
